perfluorobutane has been researched along with perflutren in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 11 (64.71) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Anderson, T; McDicken, WN; Moran, CM; Pye, SD; Sboros, V | 1 |
Baisch, C; Kuersten, B; Li, P; Liu, Z; Locricchio, E; Murthy, TH; Rafter, P; Vannan, M | 1 |
Fox, KA; McDicken, WN; Moran, CM; Watson, RJ | 1 |
Dirven, HA; Grant, D; Johnsen, H; Rasmussen, H; Videm, S; Walday, P | 1 |
Bevan, PD; Burns, PN; Karshafian, R | 1 |
Brown, DB; Chalek, CL; Dave, JK; Dianis, S; Eisenbrey, JR; Forsberg, F; Gonzalez, JM; Halldorsdottir, VG; Liu, JB; Machado, P; Merton, DA; Miller, C; Navarro, V; Park, S; Thomenius, KE | 1 |
Barr, RG; Chammas, MC; Chaubal, NG; Chen, MH; Choi, BI; Claudon, M; Clevert, DA; Correas, JM; Cosgrove, DO; Dietrich, CF; Ding, H; Forsberg, F; Fowlkes, JB; Gibson, RN; Goldberg, BB; Kudo, M; Lassau, N; Leen, EL; Mattrey, RF; Moriyasu, F; Nolsøe, CP; Piscaglia, F; Solbiati, L; Weskott, HP; Wilson, SR; Xu, HX | 1 |
Choi, K; Jung, B; Kim, C; Kim, HS; Moon, S; Oh, J; Park, D; Park, H; Park, J; Seo, J; Shin, U | 1 |
Bouakaz, A; Dayton, PA; Doinikov, AA; Sheeran, PS | 1 |
Ammi, A; Belcik, JT; Davidson, BP; Goodman, RM; Lindner, JR; Mott, BH; Seol, SH | 1 |
Daecher, A; Eisenbrey, JR; Forsberg, F; Kramer, MR | 1 |
Arena, C; Dayton, PA; High, RR; Lof, J; Porter, TR; Sayyed, S; Xie, F | 1 |
Burns, PN; Foster, FS; Sheeran, PS; Williams, R; Yin, M; Yoo, K | 1 |
Arena, CB; Chen, CC; Dayton, PA; Fix, SM; Konofagou, EE; Novell, A; Olumolade, OO; Papadopoulou, V; Wu, SY; Zheng, W | 1 |
Eisenbrey, JR; Forsberg, F; Li, J; Li, Z; Liu, JB; Machado, P; Nam, K; Stanczak, M; Wei, Y | 1 |
Hagiwara, F; Kageyama, S; Maruyama, K; Maruyama, T; Munakata, L; Omata, D; Shima, T; Suzuki, R; Suzuki, Y; Unga, J | 1 |
Hamani, C; Hynynen, K; Lea-Banks, H; O'Reilly, MA | 1 |
17 other study(ies) available for perfluorobutane and perflutren
Article | Year |
---|---|
Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents.
Topics: Albumins; Contrast Media; Coronary Circulation; Coronary Vessels; Echocardiography; Ferric Compounds; Fluorocarbons; Humans; Injections, Intravenous; Iron; Microspheres; Oxides; Phantoms, Imaging | 2000 |
Ultraharmonic myocardial contrast imaging: in vivo experimental and clinical data from a novel technique.
Topics: Adult; Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Echocardiography; Female; Fluorocarbons; Humans; Image Enhancement; Male; Microspheres; Phosphodiesterase Inhibitors; Ultrasonics | 2001 |
In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz.
Topics: Albumins; Contrast Media; Ferric Compounds; Fluorocarbons; Injections, Intravenous; Iron; Oxides; Phospholipids; Sulfur Hexafluoride; Ultrasonography | 2002 |
Intestinal and hepatic lesions in mice, rats, and other laboratory animals after intravenous administration of gas-carrier contrast agents used in ultrasound imaging.
Topics: Administration, Oral; Albumins; Animal Feed; Animals; Contrast Media; Dogs; Dose-Response Relationship, Drug; Female; Ferric Compounds; Fluorocarbons; Gases; Guinea Pigs; Injections, Intravenous; Intestinal Mucosa; Intestine, Large; Iron; Liver; Male; Mice; Mice, Inbred Strains; Necrosis; Oxides; Polysaccharides; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Ultrasonography | 2003 |
The influence of fragmentation on the acoustic response from shrinking bubbles.
Topics: Contrast Media; Diffusion; Fluorocarbons; Microbubbles; Models, Chemical; Sulfur Hexafluoride; Ultrasonics | 2008 |
Simultaneous grayscale and subharmonic ultrasound imaging on a modified commercial scanner.
Topics: Albumins; Analysis of Variance; Animals; Contrast Media; Dogs; Feasibility Studies; Ferric Compounds; Fluorocarbons; Humans; Hypertension, Portal; Iron; Oxides; Phospholipids; Pilot Projects; Sulfur Hexafluoride; Ultrasonography | 2011 |
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
Topics: Anaphylaxis; Biopsy, Needle; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraindications; Contrast Media; Diagnosis, Differential; Drug Hypersensitivity; Drug Interactions; Ferric Compounds; Fluorocarbons; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Oxides; Phospholipids; Risk Factors; Sulfur Hexafluoride; Ultrasonography, Doppler; Ultrasonography, Interventional | 2013 |
Synthesis of laboratory Ultrasound Contrast Agents.
Topics: Albumins; Cell Survival; Contrast Media; Fluorocarbons; HEK293 Cells; Humans; Lipids; Microbubbles; Particle Size; Phospholipids; Sulfur Hexafluoride; Ultrasonography | 2013 |
Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.
Topics: Acoustic Stimulation; Acoustics; Algorithms; Computer Simulation; Contrast Media; Fluorocarbons; Gases; Hydrodynamics; Microfluidics; Microscopy, Video; Models, Theoretical; Thermodynamics; Volatilization | 2014 |
Real-time contrast ultrasound muscle perfusion imaging with intermediate-power imaging coupled with acoustically durable microbubbles.
Topics: Animals; Blood Flow Velocity; Computer Systems; Contrast Media; Dogs; Elastic Modulus; Ferric Compounds; Fluorocarbons; Hardness; Iron; Materials Testing; Mice; Mice, Inbred C57BL; Microbubbles; Muscle, Skeletal; Oxides; Perfusion Imaging; Reproducibility of Results; Sensitivity and Specificity; Sound; Ultrasonography; Viscosity | 2015 |
Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents.
Topics: Albumins; Catheters; Contrast Media; Equipment Design; Equipment Failure Analysis; Ferric Compounds; Fluorocarbons; Infusions, Intravenous; Iron; Needles; Oxides; Phantoms, Imaging; Phospholipids; Reproducibility of Results; Sensitivity and Specificity; Sulfur Hexafluoride; Ultrasonography | 2015 |
Targeted Transthoracic Acoustic Activation of Systemically Administered Nanodroplets to Detect Myocardial Perfusion Abnormalities.
Topics: Animals; Contrast Media; Echocardiography; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Microcirculation; Myocardial Infarction; Nanostructures; Staining and Labeling; Swine; Transducers | 2016 |
More Than Bubbles: Creating Phase-Shift Droplets from Commercially Available Ultrasound Contrast Agents.
Topics: Animals; Contrast Media; Fluorocarbons; Image Enhancement; Liver; Mice; Mice, Inbred C3H; Microbubbles; Models, Animal; Phantoms, Imaging; Ultrasonography | 2017 |
Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery.
Topics: Acoustics; Animals; Biological Transport; Blood-Brain Barrier; Brain; Dextrans; Drug Delivery Systems; Fluorocarbons; Male; Mice; Mice, Inbred C57BL; Nanostructures; Sonication; Volatilization | 2018 |
Three-Dimensional Subharmonic Aided Pressure Estimation for Assessing Arterial Plaques in a Rabbit Model.
Topics: Animals; Blood Pressure; Contrast Media; Ferric Compounds; Fluorocarbons; Image Enhancement; Imaging, Three-Dimensional; Iron; Oxides; Plaque, Atherosclerotic; Rabbits; Ultrasonography | 2019 |
Effects of encapsulated gas on stability of lipid-based microbubbles and ultrasound-triggered drug delivery.
Topics: Animals; Brain; Contrast Media; Dextrans; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Fluorocarbons; Kidney; Lipids; Male; Mice; Microbubbles; Ultrasonic Waves | 2019 |
Localized anesthesia of a specific brain region using ultrasound-responsive barbiturate nanodroplets.
Topics: Anesthesia; Animals; Drug Delivery Systems; Fluorocarbons; Hypnotics and Sedatives; Male; Microbubbles; Nanoparticles; Pentobarbital; Rats; Rats, Sprague-Dawley; Ultrasonography | 2020 |